688197 Stock Overview
Engages in the research, development, and production of pharmaceutical drugs in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Shouyao Holdings (Beijing) Co., LTD. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥31.05 |
| 52 Week High | CN¥61.63 |
| 52 Week Low | CN¥26.81 |
| Beta | 1.24 |
| 11 Month Change | -17.97% |
| 3 Month Change | -10.78% |
| 1 Year Change | -44.42% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -37.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| 688197 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -6.1% | 0.3% | -0.6% |
| 1Y | -44.4% | -7.9% | 3.2% |
Return vs Industry: 688197 underperformed the CN Pharmaceuticals industry which returned -9.4% over the past year.
Return vs Market: 688197 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
| 688197 volatility | |
|---|---|
| 688197 Average Weekly Movement | 8.9% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 688197 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688197's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 185 | Wenjun Li | www.shouyaoholding.com |
Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of pharmaceutical drugs in China. The company offers products for various indications, such as non-small cell lung cancer, lymphoma, hepatocellular carcinoma; pancreatic, breast, ovarian, and thyroid cancer; leukemia; and other diseases, such as diabetes.
Shouyao Holdings (Beijing) Co., LTD. Fundamentals Summary
| 688197 fundamental statistics | |
|---|---|
| Market cap | CN¥4.62b |
| Earnings (TTM) | -CN¥209.50m |
| Revenue (TTM) | CN¥4.03m |
1,146x
P/S Ratio-22.0x
P/E RatioIs 688197 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688197 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.03m |
| Cost of Revenue | CN¥111.31k |
| Gross Profit | CN¥3.92m |
| Other Expenses | CN¥213.42m |
| Earnings | -CN¥209.50m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.41 |
| Gross Margin | 97.24% |
| Net Profit Margin | -5,199.60% |
| Debt/Equity Ratio | 0% |
How did 688197 perform over the long term?
See historical performance and comparison